Le Lézard
Classified in: Health, Science and technology

Reveleer Achieves HITRUST CSF ® Certification for Risk Management, Compliance, and Maximum Security


GLENDALE, Calif., Sept. 28, 2020 /PRNewswire-PRWeb/ -- Reveleer, a SaaS software and services company that offers technology solutions for government-regulated healthcare plans, announced today that they gained the HITRUST CSF Certification for information security. The HITRUST certified status further demonstrates Reveleer's commitment to their clients' safety and meets the key requirements and industry regulations for properly managing risk and safeguarding confidential data. The attainment places Reveleer in an exclusive group of organizations that have achieved this coveted certification worldwide.

"Reveleer has always been at the forefront of technology, especially around data privacy and security." said Jason Colbert, Senior Vice President of Technology. "More than HIPAA compliant, by achieving this HITRUST certification, our healthcare customers are assured the highest standards in the industry are in place to protect their sensitive data and information."

The HITRUST CSF Certification is the benchmark for organizations to guard Protected Health Information (PHI) with regards to keeping secure any identifiable health, personal, and payment information held or transmitted electronically, on paper, or otherwise. The HITRUST Program includes federal and state regulations and frameworks and provides the standards of due care and due diligence for the protection of sensitive data. The program has become the framework for organizations in the healthcare industry to incorporate a comprehensive plan of security controls and risk-based methods for managing patient data.

"Reveleer and other healthcare organizations are under great pressure to meet complex regulations," said Michael Loria CISO of Reveleer. "The HITRUST CSF is the gold-standard, and Reveleer is pleased to demonstrate our commitment to the highest levels of compliance and security by achieving HITRUST Certification."

Reveleer completed a rigorous process to earn the HITRUST Certified status, including a validated assessment in which the CSF Assurance Program scores an organization's adherence to HITRUST's standard methodology, requirements, and controls. The HITRUST CSF Program provides the standardized methods to manage data, risk and compliance via information collection and reporting, and complies with national information security and privacy laws. The HITRUST CSF incorporates and synchronizes data protection requirements from many authoritative sources?such as HIPAA, ISO, NIST, PCI ?and applies the appropriate security framework for an organization based on their regulatory risk factors. Reveleer obtained the HITRUST CSF Certification for the data protection standard in healthcare, known for its quality, thoroughness, and level of rigor in meeting industry requirements.

About Reveleer

Reveleer is a healthcare software and services company that uses Machine Learning and Intelligent Automation technology to empower payers in all lines of business to take control over their Quality Improvement and Risk Adjustment programs. The Reveleer platform enables payers to independently execute and manage every aspect of provider outreach, retrieval, coding, abstraction, and reporting ? all under one platform. Leveraging proprietary technology, robust data sets, and subject matter expertise, Reveleer also assists payers with full record retrieval and review services to support financial performance and improved member outcomes.

 

SOURCE Reveleer


These press releases may also interest you

at 07:30
Invitae Corporation , a leading medical genetics company, today announced that it will report its third quarter 2020 financial results on Thursday, November 5, 2020 and will host a conference call and webcast that day at 4:30 p.m. Eastern / 1:30 p.m....

at 07:11
AM TRACE LLC, a national, private-sector leader that helps state and local governments accelerate the effectiveness of their public health response to the COVID-19 pandemic through Case Investigation and Community Contact Tracing, announced the City...

at 07:05
Ocular Therapeutixtm, Inc. , a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will report third quarter financial...

at 07:01
/NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION/ THIS IS AN ANNOUNCEMENT FALLING UNDER...

at 07:00
Note: All times local Ottawa, Ontario Private meetings. 11:30 a.m.     The Prime Minister will make an announcement and hold a media availability. President of the Treasury Board Jean-Yves Duclos, President of the Queen's Privy Council for Canada...

at 07:00
Milestone Pharmaceuticals Inc. , a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications, today announced the pricing of its previously announced...



News published on 28 september 2020 at 10:20 and distributed by: